Company or institution

GLENMARK PHARMACEUTICALS S.A.

Save Like

110 applicationsfiled 2007 to 2025

Allowance rate

61%

−14 pts vs the USPTO range 52% to 70%

Rejections before allowance

1.4

−0.2 vs the USPTO

Months to first action

11.6 mo

−7.0 vs the USPTO

Needed an RCE

17%

−10 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations47 apps

C07D Heterocyclic compounds31 apps

C07K Peptides14 apps

C07C 6 apps

A61M Devices for introducing media into the body5 apps

A61P Therapeutic activity of compounds3 apps

Art units

162614 apps

162410 apps

16289 apps

16216 apps

16226 apps

16175 apps

Examiners met

The examiners seen most, and how it went with each

Lynn Anne Bristol5 apps

40%

Brian E McDowell5 apps

100%

Karen Cheng5 apps

100%

Chang Yu Wang4 apps

Samantha L Shterengarts4 apps

100%

Jeffrey H Murray4 apps

100%

Alicia L Otton4 apps

100%

Sun Jae Yoo3 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Glenmark Pharmaceuticals S.A.44 apps

76%

PERGAMENT & CEPEDA LLP25 apps

72%

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.22 apps

14%

RYAN, MASON & LEWIS, LLP10 apps

100%

Michael E. Carmen, Esq.5 apps

40%

Davidson Kappel LLC2 apps

50%

BENJAMIN A. ADLER1 apps

n/a

GLENMARK GENERICS INC.1 apps

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19527730	TOPICAL FOAM COMPOSITION OF ROFLUMILAST	2026-04-10	Pending	0	0	n/a
19410585	METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF	2025-12-05	Pending	0	0	n/a
19392912	METERED DOSE INHALER FOR IPRATROPIUM BROMIDE SOLUTION	2025-11-18	Pending	0	0	n/a
15375924	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15840753	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15490118	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15644504	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15852130	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15763562	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15504930	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 110 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in